Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Other Accumulated Expenses (2020 - 2024)

Historic Other Accumulated Expenses for IceCure Medical (ICCM) over the last 5 years, with Q4 2024 value amounting to $847000.0.

  • IceCure Medical's Other Accumulated Expenses fell 793.48% to $847000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $847000.0, marking a year-over-year decrease of 793.48%. This contributed to the annual value of $847000.0 for FY2024, which is 793.48% down from last year.
  • As of Q4 2024, IceCure Medical's Other Accumulated Expenses stood at $847000.0, which was down 793.48% from $3.2 million recorded in Q1 2024.
  • In the past 5 years, IceCure Medical's Other Accumulated Expenses registered a high of $3.5 billion during Q4 2022, and its lowest value of $847000.0 during Q4 2024.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $3.2 million (2022), whereas its average is $249.5 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 11842487.14% in 2022, then plummeted by 9997.34% in 2023.
  • IceCure Medical's Other Accumulated Expenses (Quarter) stood at $2.9 million in 2020, then increased by 2.1% to $2.9 million in 2021, then skyrocketed by 118424.87% to $3.5 billion in 2022, then crashed by 99.97% to $920000.0 in 2023, then fell by 7.93% to $847000.0 in 2024.
  • Its Other Accumulated Expenses was $847000.0 in Q4 2024, compared to $3.2 million in Q1 2024 and $920000.0 in Q4 2023.